New publication: Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

We review the possible role of androgens in the pathophysiology of skeletal muscle abnormalities in PCOS, and identify knowledge gaps, areas for future research and potential therapeutic implications. Despite increasing interest in the area of skeletal muscle dysfunction in women with PCOS, significant challenges and unanswered questions remain, and going forward, novel innovative approaches will be required to dissect the underlying mechanisms.
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
Recent News posts
GRANTS UPDATE
RCSI Translational Seed Funding (October 2022) Project: ‘Utilising a 3D bioprinting model to dissect the impact of androgen excess…
RCSI Collaborate - Sex Steroids Meeting
We had a really successful meeting last week with a wonderful line-up of international and local speakers for…
Society for Endocrinology - Summer Studentship
It has been an absolute pleasure to host Hunter Mangleburg as a summer research scholar for the past…
Conference news
This one day, **in-person**, mini-symposium is focused on the role of sex steroids -primarily androgens- in aging, health…